April 6, 2017
MEMS-Caps bottles have been described by some researchers and patients as "bulky,"causing concern amongst some patients about their ability to carry their medication around discretely. Most of the potential participantswho refused to enter the present study did so because of these large bottles.
However, according to the researchers, more "user-friendly" bottles that can electronically monitor and record medication use should become available for studies later this year. Such bottles should make implementation of AIMS less of a barrier for some patients.
Initiating ART soon after diagnosis has a profound personal benefit (improved health). What's more, ART also has a huge societal benefit (reduced spread of HIV). Clinical trials have found that people who take ART and who achieve and maintain an undetectable viral load do not pass on HIV to their sexual partners. These twin benefits of ART have inspired the Joint United Nations Programme on AIDS (UNAIDS) to set measureable goals to which cities, regions and countries can aspire in their quest to improve health and reduce the spread of HIV. UNAIDS encourages health authorities to try to achieve these goals, which go by the shorthand 90-90-90, by the year 2020:
If all of these goals are met by 2020, 73% of HIV-positive people in a city, region or country would have an undetectable viral load, and therefore the risk of HIV transmission would be greatly reduced.
Researchers at the University of Washington in Seattle who have reviewed the Dutch research have noted that adherence "remains the primary obstacle to achieving the best outcome for patients receiving [ART]."
As countries and regions race to try to achieve the final 90 (90% of ART users will have an undetectable viral load) by 2020, programs such as AIMS could help play a pivotal role in ensuring high rates of success.
What reduces survival 10 years after starting ART in North America and Europe? -- TreatmentUpdate 217
Challenges in achieving a longer life -- TreatmentUpdate 214
Longer life expectancy for HIV-positive people in North America -- TreatmentUpdate 200
Exploring factors linked to longer survival among ART users -- TreatmentUpdate 200
|Nurse-Led PrEP Clinic in San Francisco Shares Model of Success at AIDS 2016|
|Ottawa Study Finds Nurse-Led PEP Clinic Works|
|Nurses Are Primary HIV Care Providers, But Go Unrecognized and Unsupported|
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.